Health Care & Life Sciences » Pharmaceuticals | Adcock Ingram Holdings Ltd.

Adcock Ingram Holdings Ltd. | Balance Sheet

Fiscal year is July-June. All values ZAR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
248
147
201
592
405
Total Accounts Receivable
1,254
1,428
1,461
1,522
1,647
Inventories
1,106
1,208
1,167
1,157
1,566
Other Current Assets
58
59
632
55
-
Total Current Assets
2,666
2,842
3,461
3,326
3,618
Net Property, Plant & Equipment
1,554
1,491
1,423
1,445
1,521
Total Investments and Advances
205
282
356
400
477
Long-Term Note Receivable
136
88
72
40
-
Intangible Assets
836
743
276
350
626
Total Assets
5,406
5,458
5,597
5,563
6,271
ST Debt & Current Portion LT Debt
325
317
12
6
249
Accounts Payable
624
672
727
749
1,839
Income Tax Payable
1
3
5
12
-
Other Current Liabilities
550
730
1,005
959
133
Total Current Liabilities
1,500
1,723
1,749
1,727
2,221
Long-Term Debt
1,005
514
500
251
-
Provision for Risks & Charges
22
23
17
17
16
Deferred Taxes
13
70
68
72
101
Total Liabilities
2,548
2,341
2,342
2,068
2,356
Common Equity (Total)
2,739
3,017
3,229
3,487
3,913
Total Shareholders' Equity
2,739
3,017
3,229
3,487
3,913
Total Equity
2,857
3,117
3,255
3,495
3,915
Liabilities & Shareholders' Equity
5,406
5,458
5,597
5,563
6,271
Accumulated Minority Interest
119
100
26
8
2

About Adcock Ingram Holdings

View Profile
Address
1 New Road
Midrand GT 1682
South Africa
Employees -
Website http://www.adcock.co.za
Updated 07/08/2019
Adcock Ingram Holdings Ltd. is a pharmaceutical company. It operates through the following segments: Over the Counter, Consumer, Prescription and Hospital. The Over the Counter segment focuses primarily on brands sold predominantly in the pharmacy market, where the pharmacist plays a role in the product choice.